清利泄浊祛痛汤联合西药治疗急性痛风性关节炎湿热蕴结证疗效观察
Observation on the Efficacy of Qingli Xiezhuo Qutong Decoction Combined with Western Medicine for the Treatment of Acute Gouty Arthritis with Damp-Heat Accumulation Syndrome
-
摘要: 目的 观察清利泄浊祛痛汤联合西药治疗急性痛风性关节炎(湿热蕴结证)的临床疗效。方法 将70例患者按随机数字表法分为对照组和治疗组各35例。对照组给予秋水仙碱片口服,初始剂量1 mg,随后0.5 mg/h,症状缓解后0.5 mg/次,3 次/d。治疗组在对照组的基础上,给予清利泄浊祛痛汤,每日1剂。2组疗程均为7 d。记录治疗前后关节疼痛评分、关节肿胀评分、中医证候评分;检测治疗前后患者血白细胞(WBC)、红细胞沉降率(ESR)、C反应蛋白(CRP)、血尿酸(BUA)、肿瘤坏死因子-α(TNF-α)、白细胞介素-1(IL-1)水平,并进行安全性评价。结果 治疗后治疗组临床疗效优于对照组(P<0.05);2组患者关节疼痛评分、关节肿胀评分、中医证候评分及CRP、ESA、TNF-α、IL-1、BUA水平明显降低(P<0.01),治疗组优于对照组(P<0.05~0.01)。结论 在秋水仙碱治疗的基础上,采用清利泄浊祛痛汤治疗急性痛风性关节炎(湿热蕴结证)可有效缓解其主要临床症状,减轻炎症反应,安全性较好,临床疗效优于单纯的西医治疗。Abstract: OBJECTIVE To observe the clinical efficacy of Qingli Xiezhuo Qutong Decoction in combination with Western medicine for the treatment of acute gouty arthritis with damp-heat accumulation syndrome. METHODS 70 patients were randomly divided into the control group and the treatment groups with 35 cases each. The control group was given colchicine tablets orally at an initial dose of 1 mg, followed by 0.5 mg per hour and 0.5 mg at a time, for 3 times per day when symptom was relieved, and the treatment group was given Qingli Xiezhuo Qutong Decoction one dose a day. Both groups were treated for 7 days. The joint pain score, joint swelling score, and traditional Chinese medicine (TCM) syndrome score were recorded before and after treatment, and blood leukocyte (WBC), erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), blood uric acid (BUA), tumor necrosis factor-α (TNF-α), interleukin-1 (IL-1) levels were tested before and after treatment, and safety evaluation was conducted. RESULTS The clinical efficacy of the treatment group was better than that of the control group after treatment (P<0.05). Joint pain score, joint swelling score, TCM syndrome score and CRP, ESA, TNF-α, IL-1, BUA levels were significantly reduced in both groups (P<0.01) and the treatment group was better than the control group (P<0.05, P<0.01). CONCLUSION On the basis of colchicine, Qingli Xiezhuo Qutong Decoction for acute gouty arthritis (damp-heat accumulation syndrome) can effectively relieve the main clinical symptoms reducing the inflammatory response, with better safety and clinical efficacy than that of pure western medicine.
-
[1] 胥少汀,葛宝丰,徐印坎.实用骨科病学[M].北京:人民军医出版社,2016:1662. [2] 中华医学会内分泌学分会.高尿酸血症和痛风治疗的中国专家共识[J].中华内分泌代谢杂志,2013,29(11):913-919. [3] 王承德,沈丕安,胡荫奇.实用中医风湿病学[M].北京:人民卫生出版社,2009:58-60. [4] NEOGI T, JANSEN TL,DALBETH N,et al. 2015 gout classification criteria: An American college of rheumatology european league against rheumatism collaborative initiative[J]. Arthritis Rheumatol, 2015,67(10):2557-2568. [5] 国家中医药管理局.22个专业95个病种中医诊疗方案[M].北京:中国中医药出版社,2011:253-291. [6] 国家药品监督管理局.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002:192-195. [7] 国家中医药管理局.中医病证诊断疗效标准[S].北京:中国医药科技出版社,2012:50-51. [8] 朱英,朱青青,詹广生,等.刺血结合药线对急性痛风性关节炎大鼠血清代谢组学的影响[J].辽宁中医杂志,2019,46(1):190-196,226. [9] 周梦泽.兼具降尿酸活性的固有免疫受体抑制剂的发现及其治疗痛风的分子机制研究[D].南京:南京医科大学,2019. [10] 杨西超,郑朝晖,牛敏,等.痛风性关节炎患者血清白细胞介素-1β、肿瘤坏死因子-α和环氧化酶-2水平变化及临床意义[J].新乡医学院学报,2019,36(8):752-754. [11] 〖JP2〗梁宏,蔡惠芳,徐佳妮.箭羽散对湿热型痛风性关节炎患者血清IL-1β、IL-6、TNF-α表达的影响[J].吉林中医药,2019,39(8):1059-1062.〖JP〗 [12] 〖JP2〗赵用,马宝东,陈岩松,等.苓泽合剂对急性痛风性关节炎大鼠血IL-1β表达影响[J].辽宁中医药大学学报,2018,20(7):43-46.〖JP〗 [13] 舒碧莹,蒋麒俊,蔡枫. ANCA、IL-1、IL-6、TNF-α四项检测诊断类风湿性关节炎的研究进展[J].国际检验医学杂志,2019,40(4):448-452. [14] 〖JP2〗刘湘玲,韩德军,杨锡燕.当代名老中医治疗急性痛风性关节炎经验用药规律[J].中国实验方剂学杂志,2017,23(2):187-192.〖JP〗 [15] 李壮,侯堃.316例男性急性痛风性关节炎中医证候分类研究[J].中医杂志,2019,60(1):47-50.
点击查看大图
计量
- 文章访问数: 485
- HTML全文浏览量: 6
- PDF下载量: 396
- 被引次数: 0